Targeting Angiotensin II levels by using Angiotensin-converting enzyme inhibitors (ACEIs) is the most commonly used medication for the treatment of cardiovascular diseases, including but not limited to heart failure, acute coronary syndrome, and hypertension (71, 72). This evidence concerns the gene AGT and acute coronary syndrome.